Advertisement

Topics

Precipio Diagnostics and Transgenomic Complete Merger

07:00 EDT 30 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Company Renamed Precipio, Inc.--To Commence Trading On NASDAQ Under The New Ticker "PRPO" Precipio Diagnostics, LLC and Transgenomic Inc. (OTCQB: TBIOD) today announced the closing of their previously announced merger. In ...

Other Sources for this Article

Precipio Investor Relations
Scott Gordon, 516-222-2560
President
CORE IR
377 Oak Street
Garden City, NY 11530
scottg@coreir.com
www.coreir.com

NEXT ARTICLE

More From BioPortfolio on "Precipio Diagnostics and Transgenomic Complete Merger"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...